Omeprazole vs H2 Blockers UK | Acid Reflux Guide

Clinically Proven UK Registered Pharmacy

Omeprazole vs H2 Blockers: Comparing Acid Reflux Treatments

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Person using Cured Pharmacy online consultation for acid reflux treatment
From £9.99 Starting dose — clinically approved
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Esomeprazole 20mg – 28 pack - UK-licensed prescription Treatment
Treatment

Esomeprazole 20mg – 28 pack

From £9.99

Future orders save 5%
Start Assessment
Lansoprazole Capsules (30mg & 15mg) - UK-licensed prescription Treatment
Treatment

Lansoprazole Capsules (30mg & 15mg)

From £9.99

Future orders save 5%
Start Assessment
Pantoprazole Gastro Resistant Tablets (20mg & 40mg) - UK-licensed prescription Treatment
Treatment

Pantoprazole Gastro Resistant Tablets (20mg & 40mg)

From £10.99

Future orders save 5%
Start Assessment
Pyrocalm 20mg - UK-licensed prescription Treatment
Treatment

Pyrocalm 20mg

From £8.49

Future orders save 5%
Start Assessment
Nexium Tablets 40mg - UK-licensed prescription Treatment
Treatment

Nexium Tablets 40mg

From £17.99

Future orders save 5%
Start Assessment
Losec Capsules & Tablets (Omeprazole) 20mg - UK-licensed prescription Treatment
Treatment

Losec Capsules & Tablets (Omeprazole) 20mg

From £14.99

Future orders save 5%
Start Assessment

Omeprazole vs H2 Blockers: Comparing Acid Reflux Treatments

Published on: June 03, 2026

When comparing omeprazole vs H2 blockers UK options, understanding the fundamental differences between proton pump inhibitors (PPIs) and H2 receptor antagonists is essential for effective acid reflux management. At Cured Pharmacy, our UK-registered clinical team helps patients navigate these treatment choices with transparent pricing and expert guidance. Both medication classes reduce stomach acid production, but they work through different mechanisms and offer varying levels of symptom control.

How Omeprazole and H2 Blockers Work Differently

Omeprazole belongs to the proton pump inhibitor (PPI) class, which works by irreversibly blocking the hydrogen-potassium ATPase enzyme system (the 'proton pump') in gastric parietal cells [1]. This mechanism prevents acid secretion at the final stage of production, reducing gastric acid by up to 90% over 24 hours. The effect builds gradually, with maximum acid suppression typically achieved after 3-4 days of consistent dosing.

H2 receptor antagonists, historically including ranitidine (now withdrawn from the UK market) and currently represented by famotidine, work by competitively blocking histamine H2 receptors on parietal cells [2]. This prevents histamine from stimulating acid production, reducing gastric acid output by approximately 60-70%. H2 blockers act more rapidly than PPIs, with onset within 30-60 minutes, but provide less profound acid suppression overall.

The critical distinction lies in duration and depth of action. PPIs offer longer-lasting acid control because they bind covalently to the proton pump, requiring new enzyme synthesis for acid production to resume. H2 blockers provide faster but shorter relief, with effects typically lasting 6-10 hours compared to the 24-hour coverage most PPIs deliver [1][2].

Clinical Efficacy: Omeprazole vs H2 Blockers for GORD

Meta-analyses consistently demonstrate superior healing rates for PPIs compared to H2 receptor antagonists in gastro-oesophageal reflux disease (GORD). At 8 weeks, omeprazole 20mg once daily achieves oesophagitis healing in approximately 84% of patients, whilst H2 blockers achieve healing in around 52% of cases [3]. For erosive oesophagitis specifically, the difference becomes even more pronounced, with PPIs demonstrating healing rates up to 30% higher than H2 antagonists.

Symptom relief follows similar patterns. In comparative trials, patients taking omeprazole reported complete heartburn resolution within 2 weeks in 65-75% of cases, compared to 40-50% with H2 blockers [3]. The NICE clinical guideline CG184 recognises this efficacy difference, recommending PPIs as first-line treatment for GORD and reserving H2 blockers primarily for patients who cannot tolerate PPIs or require only mild symptom control.

However, H2 blockers maintain a role for specific scenarios. Their rapid onset makes them suitable for on-demand relief of occasional symptoms, and they demonstrate less risk of tolerance development during intermittent use. Some patients achieve adequate control with H2 antagonists for mild, infrequent reflux, avoiding the need for more potent acid suppression.

Treatment Selection Based on Symptom Severity

Your UK prescriber will assess symptom frequency, severity, and any evidence of oesophageal damage when recommending between omeprazole and H2 blockers. Patients experiencing daily heartburn, nocturnal symptoms, or those with confirmed erosive oesophagitis typically require PPI therapy. Those with mild, occasional symptoms occurring less than twice weekly may achieve satisfactory control with H2 receptor antagonists or antacids. At Cured Pharmacy, our clinical assessment considers your complete symptom profile to recommend the most appropriate treatment, with omeprazole available from £9.99 and alternative PPIs offering additional options for tailored therapy.

Side Effect Profiles and Safety Considerations

Both medication classes demonstrate generally favourable safety profiles, though their side effect patterns differ. Common omeprazole side effects include headache (occurring in 2-7% of patients), gastrointestinal disturbances such as nausea, diarrhoea, or constipation (3-5%), and abdominal pain (1-3%) [4]. Long-term PPI use has been associated with potential risks including reduced magnesium absorption, slightly increased fracture risk with prolonged high-dose therapy, and rare cases of vitamin B12 deficiency, though these concerns primarily affect continuous use beyond 12 months.

H2 receptor antagonists typically cause fewer side effects overall, with famotidine demonstrating headache (4-5%), dizziness (1-2%), and constipation or diarrhoea (1-2%) as the most frequently reported issues [2]. The previous concerns about ranitidine and NDMA contamination led to its UK market withdrawal in 2020, but famotidine has not demonstrated similar contamination issues and remains available.

Drug interactions warrant consideration with both classes. Omeprazole can affect the metabolism of certain medications including clopidogrel, warfarin, and some antifungals through cytochrome P450 enzyme inhibition [4]. H2 blockers demonstrate fewer significant drug interactions, though famotidine may affect the absorption of medications requiring acidic environments. Your UK prescriber will review your complete medication list during clinical assessment to identify any potential interactions before recommending treatment.

Feature Omeprazole (PPI) H2 Blockers
Mechanism Blocks proton pump (final acid production step) Blocks histamine H2 receptors
Acid Suppression Up to 90% reduction over 24 hours 60-70% reduction for 6-10 hours
Onset of Action Maximum effect after 3-4 days 30-60 minutes
Healing Rate (8 weeks) ~84% for oesophagitis ~52% for oesophagitis
Dosing Frequency Once daily Twice daily or more
NICE Recommendation First-line for GORD Alternative for mild symptoms
Starting Price at Cured From £5.99 Limited UK availability

Omeprazole vs H2 Blockers: Cost and Accessibility in the UK

Omeprazole offers excellent value as a first-line acid reflux treatment in the UK, with generic formulations providing cost-effective access to proven PPI therapy. At Cured Pharmacy, omeprazole capsules start from £9.99, representing competitive pricing for this established treatment. The medication's patent expiry has enabled widespread generic availability, making it one of the most accessible prescription acid reflux treatments across UK pharmacies.

Alternative PPIs provide additional options for patients requiring different formulations or dosing schedules. Lansoprazole capsules offer once-daily convenience from £9.99, whilst esomeprazole (the S-isomer of omeprazole) provides enhanced acid control for some patients from £9.99. Pantoprazole gastro-resistant tablets, available from £9.99, suit patients preferring tablet formulations. For over-the-counter options, Pyrocalm 20mg (omeprazole) offers short-term self-treatment from £9.99, though prescription-strength courses provide better value for ongoing management.

H2 receptor antagonists, whilst previously available over-the-counter, now have limited UK availability following ranitidine's withdrawal. Famotidine remains accessible through prescription or pharmacy supply, though it's less commonly stocked than PPIs. The combination of superior efficacy, competitive pricing, and widespread availability has positioned omeprazole and other PPIs as the preferred choice for most UK patients requiring acid reflux treatment.

Accessing Treatment Through Cured Pharmacy

All prescription acid reflux medications require clinical assessment by a UK prescriber before dispensing. At Cured Pharmacy, our streamlined online consultation takes under 3 minutes and is reviewed by UK-registered prescribers who assess your suitability for treatment. We offer transparent upfront pricing with no hidden consultation fees, and all medications are genuine UK-licensed products dispensed by our GPhC-registered pharmacy (9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073). Discreet packaging and reliable delivery ensure your treatment arrives promptly and privately.

When to Choose Omeprazole Over H2 Blockers

Omeprazole and other PPIs represent the optimal choice for patients experiencing frequent heartburn (more than twice weekly), confirmed erosive oesophagitis, or symptoms that significantly impact quality of life [3]. The superior acid suppression achieved by PPIs makes them essential for healing oesophageal damage and preventing complications such as Barrett's oesophagus in susceptible patients. NICE guidelines recommend PPIs as first-line therapy for GORD, reflecting the substantial evidence base supporting their efficacy.

Specific clinical scenarios particularly favour PPI therapy. Patients with nocturnal reflux symptoms, those requiring NSAID co-prescription with gastroprotection, and individuals with Helicobacter pylori eradication regimens all benefit from PPI treatment. The once-daily dosing schedule improves adherence compared to the multiple daily doses some H2 blockers require for equivalent coverage. Additionally, patients who have previously tried H2 antagonists without adequate symptom control should step up to PPI therapy rather than persisting with insufficient treatment.

Starting with omeprazole 20mg once daily before breakfast provides effective symptom control for most patients, with the option to adjust dosing based on response. Treatment typically continues for 4-8 weeks initially, with assessment of symptom resolution guiding whether to continue, reduce, or stop therapy. Your UK prescriber will establish an appropriate treatment plan during your clinical consultation, considering both symptom severity and any underlying conditions requiring longer-term acid suppression.

Alternative PPI Options Beyond Omeprazole

Whilst omeprazole remains the most prescribed PPI in the UK, alternative proton pump inhibitors offer valuable options for patients requiring different pharmacokinetic profiles or those experiencing inadequate response. Esomeprazole, the S-enantiomer of omeprazole, provides slightly enhanced acid suppression and may benefit patients with severe erosive oesophagitis [5]. Available at Cured Pharmacy from £9.99, esomeprazole 20mg offers once-daily dosing with proven efficacy in GORD management.

Lansoprazole represents another well-established PPI option, with comparable efficacy to omeprazole and the advantage of orodispersible formulations for patients with swallowing difficulties. Zoton FasTab, available from £9.99, dissolves on the tongue without water, improving convenience for some patients. Pantoprazole gastro-resistant tablets, from £9.99, demonstrate excellent tolerability and fewer drug interactions than some PPIs, making them suitable for patients on complex medication regimens.

Branded formulations such as Losec (omeprazole) and Nexium (esomeprazole) provide additional choices for patients preferring original manufacturer products. Losec capsules and tablets start from £9.99, whilst Nexium 40mg tablets are available from £9.99. The clinical team at Cured Pharmacy can guide you through these options during your online consultation, recommending the most appropriate PPI based on your symptoms, medical history, and treatment preferences. All prescription PPIs require clinical assessment by a UK prescriber, ensuring safe and appropriate use for your individual circumstances.

Combining Lifestyle Modifications with Medication

Optimal acid reflux management combines pharmacological treatment with lifestyle adjustments. Elevating the head of your bed by 15-20cm, avoiding meals within 3 hours of bedtime, and identifying personal trigger foods enhance medication efficacy. Weight loss in overweight patients, smoking cessation, and moderating alcohol intake all contribute to symptom reduction. Your UK prescriber will discuss these complementary strategies alongside medication recommendations, creating a comprehensive treatment approach that addresses both symptoms and underlying contributing factors.

Scientific References

  1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
  2. Kahrilas, P. J., & Howden, C. W. (2000). The spectrum of H2-receptor antagonist therapy in gastroesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 14(Suppl 1), 11–16. https://doi.org/10.1046/j.1365-2036.2000.014s1011.x [accessed 13 August 2026]
  3. Chiba, N., De Gara, C. J., Wilkinson, J. M., & Hunt, R. H. (1997). Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology, 112(6), 1798–1810. https://doi.org/10.1053/gast.1997.v112.pm9178669 [accessed 13 August 2026]
  4. Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver, 11(1), 27–37. https://doi.org/10.5009/gnl15502 [accessed 13 August 2026]
  5. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19–31. https://doi.org/10.1007/s00228-008-0576-5 [accessed 13 August 2026]
  6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Faq

Is omeprazole stronger than H2 blockers?
Yes, omeprazole and other PPIs provide more profound acid suppression than H2 blockers, reducing gastric acid by up to 90% compared to 60-70% with H2 antagonists. Clinical trials demonstrate superior healing rates and symptom control with PPIs for moderate to severe GORD.
Can I switch from H2 blockers to omeprazole?
Yes, switching from H2 blockers to omeprazole is common when symptoms remain inadequately controlled. Your UK prescriber will assess your response to current treatment and recommend stepping up to PPI therapy if appropriate, with no washout period typically required between medications.
Which is safer long-term: omeprazole or H2 blockers?
Both medication classes demonstrate acceptable long-term safety profiles when used appropriately. H2 blockers have fewer documented long-term concerns, whilst PPIs require monitoring for magnesium levels and bone health during prolonged high-dose use. Your prescriber will recommend the lowest effective dose for the shortest necessary duration.
Do omeprazole and H2 blockers work immediately?
H2 blockers provide faster symptom relief, working within 30-60 minutes, whilst omeprazole requires 3-4 days of consistent dosing to achieve maximum acid suppression. For immediate relief, antacids work fastest, but PPIs offer superior long-term symptom control.
Can I take omeprazole and H2 blockers together?
Combining PPIs with H2 blockers is not routinely recommended, as PPIs already provide maximum acid suppression and adding H2 blockers offers minimal additional benefit. Your UK prescriber will optimise your PPI regimen before considering combination therapy, which is reserved for specific refractory cases.
Why was ranitidine withdrawn but omeprazole remains available?
Ranitidine was withdrawn from the UK market in 2020 due to unacceptable levels of NDMA (a probable carcinogen) found in some formulations. Omeprazole and other PPIs have not demonstrated similar contamination issues and remain fully licensed by the MHRA for UK use with established safety profiles.
How long can I take omeprazole vs H2 blockers?
Both medications can be used long-term when clinically necessary, though PPIs should be prescribed at the lowest effective dose. Initial treatment courses typically last 4-8 weeks, with ongoing use reviewed regularly by your prescriber. Some patients require continuous therapy for conditions like Barrett's oesophagus, whilst others achieve symptom control with intermittent or on-demand dosing.
Are there over-the-counter options for omeprazole vs H2 blockers in the UK?
Omeprazole 20mg is available over-the-counter for short-term use (maximum 4 weeks), with products like Pyrocalm offering accessible self-treatment from £9.99. H2 blocker availability is limited following ranitidine's withdrawal, with famotidine requiring pharmacy supply or prescription. For ongoing acid reflux management, prescription-strength courses provide better value and appropriate clinical oversight.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.